Annual Monitoring for Patients on Persistent Medications (MPM) by Subpopulation: Ace Inhibitors or ARBs

HEDIS® Measurement Description: The percentage of members 18 years of age and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year.

Measure Identifier: HEDIS_MPM.01_SUB

Please see Report Details below for more information on selected subgroups, organizations, and aggregation.